Chemours (CC)
(Delayed Data from NYSE)
$19.79 USD
-0.66 (-3.23%)
Updated Nov 8, 2024 04:00 PM ET
After-Market: $19.80 +0.01 (0.05%) 7:58 PM ET
3-Hold of 5 3
C Value F Growth C Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$19.79 USD
-0.66 (-3.23%)
Updated Nov 8, 2024 04:00 PM ET
After-Market: $19.80 +0.01 (0.05%) 7:58 PM ET
3-Hold of 5 3
C Value F Growth C Momentum F VGM
Zacks News
Mosaic (MOS) to Report Q3 Earnings: What's in the Cards?
by Zacks Equity Research
Mosaic's (MOS) Q3 results are likely to reflect the benefits of higher prices and demand for phosphate and potash.
Is The Chemours (CC) Stock Outpacing Its Basic Materials Peers This Year?
by Zacks Equity Research
Is (CC) Outperforming Other Basic Materials Stocks This Year?
LyondellBasell (LYB) to Post Q3 Earnings: What's in Store?
by Zacks Equity Research
LyondellBasell's (LYB) Q3 performance is likely to have benefited from strong consumer-driven demand and continued recovery in the durable goods market.
AdvanSix (ASIX) to Report Q3 Earnings: What's in the Offing?
by Zacks Equity Research
AdvanSix (ASIX) is expected to have benefited from strong end-market demand, higher prices and growth of its differentiated products in Q3.
Nutrien (NTR) to Post Q3 Earnings: What's in the Cards?
by Zacks Equity Research
Nutrien's (NTR) third-quarter results are likely to reflect the benefits of strong demand and higher prices for fertilizers.
Chemours (CC) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Chemours (CC) closed at $28.95, marking a -1.63% move from the previous day.
Sherwin-Williams (SHW) Earnings & Sales Beat Estimates in Q3
by Zacks Equity Research
Sherwin-Williams' (SHW) Q3 results benefit from strong demand in its pro-architectural and industrial end markets amid headwinds from raw material supply chain challenges.
Eastman Chemical (EMN) to Post Q3 Earnings: What's in Store?
by Zacks Equity Research
Eastman Chemical's (EMN) Q3 performance is likely to have benefited from cost-management actions and new business revenues from innovation.
Newmont (NEM) to Post Q3 Earnings: What's in the Cards?
by Zacks Equity Research
Newmon''s (NEM) results in the third quarter are likely to reflect the weakness in gold prices.
Chemours (CC) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Chemours (CC) closed the most recent trading day at $29.43, moving +0.82% from the previous trading session.
Are Investors Undervaluing Chemours (CC) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Methanex (MEOH) to Post Q3 Earnings: What's in the Cards?
by Zacks Equity Research
Methanex's (MEOH) third-quarter performance is likely to reflect healthy methanol demand and improvement in pricing.
Can Linde (LIN) Keep the Earnings Surprise Streak Alive in Q3?
by Zacks Equity Research
Higher industrial gas sales are likely to have aided Linde???s (LIN) Q3 earnings.
U.S. Steel (X) to Post Q3 Earnings: What's in the Cards?
by Zacks Equity Research
U.S. Steel's (X) Q3 results are likely to have benefited from strong demand across end markets and higher domestic steel prices.
Sherwin-Williams (SHW) to Post Q3 Earnings: What's in Store?
by Zacks Equity Research
Sherwin-Williams' (SHW) third-quarter performance is likely to reflect strong demand and cost-control initiatives.
4 Chemical Stocks Set to Pull Off a Beat This Earnings Season
by Anindya Barman
Strong end-market demand and benefits of self-help actions are likely to reflect on the Q3 performance of Westlake (WLK), Tronox (TROX) and Chemours (CC) and Albemarle (ALB).
Freeport's (FCX) Q3 Earnings Top, Revenues Lag Estimates
by Zacks Equity Research
Freeport's (FCX) Q3 earnings gain from higher realized prices and lower costs.
PPG Industries (PPG) Tops Q3 Earnings and Revenue Estimates
by Zacks Equity Research
PPG Industries (PPG) Q3 results are driven by higher selling prices, offset by raw material cost inflation and lower sales volumes.
Barrick (GOLD) Q3 Production Rises, Set to Achieve FY21 Targets
by Zacks Equity Research
Barrick (GOLD) reports preliminary third-quarter sales of 1.07 million ounces of gold as well as preliminary production of 1.09 million ounces.
Cleveland-Cliffs (CLF) to Report Q3 Earnings: What's in Store?
by Zacks Equity Research
Cleveland-Cliffs (CLF) is expected to have benefited from higher steel demand and prices and contributions from acquisitions in Q3.
Will Higher Selling Prices Drive Nucor's (NUE) Q3 Earnings?
by Zacks Equity Research
Profitability across Nucor's (NUE) steel mills and steel products segments is expected to have boosted by higher average sales prices in Q3.
Olin (OLN) to Report Q3 Earnings: What's in the Offing?
by Zacks Equity Research
Olin's (OLN) Q3 performance is likely to have benefited from productivity actions and strong performance in the Winchester business.
Will Chemours (CC) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Chemours (CC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Chemours (CC) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Chemours (CC) closed the most recent trading day at $30.64, moving -0.81% from the previous trading session.
Chemours (CC) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Chemours (CC) closed at $30.91 in the latest trading session, marking a -1.47% move from the prior day.